Khichar Purnaram Shubhakaran, Rekha Jakhar Khichar
Department of Neurology, Obstetrics and Gynaecology, Dr. S. N. Medical College, Jodhpur, Rajasthan, India.
DOI: 10.4103/jnsbm.JNSBM_155_17

We read an interesting observational study by Das et al.[1] The study is worth appreciation and may be considered a milestone in this direction in India. There are certain views which we would like to share as under: Providing cheaper medicines and other treatment-related aids such as stents and prostheses should be priority in all the hospitals or health-care centers whether private or government and the Government of India is committed in this direction There are certain drugs where the therapeutic window or the safety margin is very narrow like phenytoin or any of the antiepileptic drugs [2] where the levels cannot be measured or affordable, as is with anticoagulants and antiplatelets. We should take appropriate measures in this direction to fight the cost of medicines along with maintaining the treatment and management quality. Implementation of such measures to provide cheaper medicines, will also safeguard the precious image of the novel medical profession, the government should also maintain strict quality control measures [3]. Read more…